Amgen Inc.
AMGN
$305.70
-$1.22-0.40%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 26.91B | 25.63B | 25.32B | 24.92B | 24.80B |
| Total Other Revenue | 1.28B | 1.20B | 1.26B | 1.27B | 1.52B |
| Total Revenue | 28.19B | 26.83B | 26.58B | 26.19B | 26.32B |
| Cost of Revenue | 8.45B | 7.09B | 6.87B | 6.57B | 6.41B |
| Gross Profit | 19.74B | 19.75B | 19.71B | 19.63B | 19.92B |
| SG&A Expenses | 6.17B | 5.46B | 5.41B | 5.44B | 5.41B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 670.00M | 43.00M | 63.00M | 548.00M | 546.00M |
| Total Operating Expenses | 20.04B | 17.15B | 16.93B | 17.09B | 16.80B |
| Operating Income | 8.15B | 9.68B | 9.65B | 9.10B | 9.52B |
| Income Before Tax | 7.86B | 8.75B | 9.20B | 9.11B | 7.35B |
| Income Tax Expenses | 1.14B | 1.19B | 1.22B | 1.20B | 794.00M |
| Earnings from Continuing Operations | 6.72K | 7.57K | 7.98K | 7.92K | 6.55K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.72B | 7.57B | 7.98B | 7.92B | 6.55B |
| EBIT | 8.15B | 9.68B | 9.65B | 9.10B | 9.52B |
| EBITDA | 12.22B | 13.29B | 13.19B | 12.58B | 12.94B |
| EPS Basic | 12.57 | 14.15 | 14.92 | 14.81 | 12.18 |
| Normalized Basic EPS | 8.19 | 10.56 | 10.29 | 11.02 | 8.85 |
| EPS Diluted | 12.49 | 14.06 | 14.82 | 14.70 | 12.10 |
| Normalized Diluted EPS | 8.14 | 10.49 | 10.22 | 10.95 | 8.80 |
| Average Basic Shares Outstanding | 2.14B | 2.14B | 2.14B | 2.14B | 2.15B |
| Average Diluted Shares Outstanding | 2.15B | 2.15B | 2.15B | 2.15B | 2.17B |
| Dividend Per Share | 8.52 | 8.33 | 8.14 | 7.95 | 7.76 |
| Payout Ratio | 67.83% | 58.90% | 54.57% | 53.72% | 64.04% |
